Cost effectiveness of colorectal cancer screening strategies

Cancer Control

Volumn 22, Issue 2, 2015, Pages 248-258

  Patel, Shaan S ^a   Kilgore, Meredith L ^a,b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; HEALTH CARE COST; HUMAN; IMMUNOCHEMISTRY; OCCULT BLOOD TEST; SIGMOIDOSCOPY; SYSTEMATIC REVIEW; COLORECTAL NEOPLASMS; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; IMMUNOHISTOCHEMISTRY; OCCULT BLOOD; PROCEDURES; UNITED STATES;

COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; IMMUNOHISTOCHEMISTRY; OCCULT BLOOD; SIGMOIDOSCOPY; UNITED STATES;

EID: 84930982624     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481502200219     Document Type: Article

References (26)

1. American Cancer Society. Cancer Facts & Figures 2015. Atlanta, GA: American Cancer Society; 2015. http://www.cancer.org/acs/groups/ content/@editorial/documents/document/acspc-044552.pdf. Accessed February 12, 2015.
2. Elmunzer BJ, Hayward RA, Schoenfeld PS, et al. Effect of flexible sig-moidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9(12):e1001352.
3. Libby G, Brewster DH, McClements PL, et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer. 2012;107(2):255-259.
4. Schoen RE, Pinsky PF, Weissfeld JL, et al; PLCO Project Team. Col-orectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345-2357.
5. Young PE, Womeldorph CM. Colonoscopy for colorectal cancer screening. J Cancer. 2013;4(3):217-226.
6. US Preventive Services Task Force. Colorectal cancer: screening. Published October 2008. http://www.uspreventiveservicestaskforce.org/ Page/Topic/recommendation-summary/colorectal-cancer-screening. Accessed January 21, 2015
7. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33(1):88-100.
8. Pignone M, Saha S, Hoerger T, et al. Challenges in systematic reviews of economic analyses. Ann Intern Med. 2005;142(12 pt 2):1073-1079.
9. Hassan C, Pickhardt PJ, Laghi A, et al. Impact of whole-body CT screening on the cost-effectiveness of CT colonography. Radiology. 2009;251(1):156-165.
10. Dinh T, Ladabaum U, Alperin P, et al. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol. 2013;11(9):1158-1166.
11. Hassan C, Pickhardt PJ, Laghi A, et al. Computed tomographic colo-nography to screen for colorectal cancer, extracolonic cancer, and aortic an eurysm: model simulation with cost-effectiveness analysis. Arch Intern Med. 2008;168(7):696-705.
12. Hassan C, Hunink MG, Laghi A, et al. Value-of-information analysis to guide future research in colorectal cancer screening. Radiology. 2009; 253(3):745-752.
13. Hassan C, Rex DK, Zullo A, Cooper GS. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists. Cancer. 2012;118(18):4404-4411.
14. Jonas DE, Russell LB, Sandler RS, et al. Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study. Med Decis Making. 2008;2008:28(1):56-65.
15. Sonnenberg A, Delco F, Bauerfeind P. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer? Am J Gastroenterol. 1999;94(8):2268-2274.
16. Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, et al. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the Medicare population. J Natl Cancer Inst. 2010;102(16):1238-1252.
17. Ladabaum U, Allen J, Wandell M, et al. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies. Cancer Epidemiol Biomarkers Prev. 2013;22(9):1567-1576.
18. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, et al. Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Intern Med. 2010;153(6):368-377.
19. Parekh M, Fendrick AM, Ladabaum U. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment PharmacolTher. 2008;27(8):697-712.
20. Pickhardt PJ, Hassan C, Laghi A, et al. Cost-effectiveness of colorectal cancer screening with computed tomography colonography: the impact of not reporting diminutive lesions. Cancer. 2007;109(11):2213-2221.
21. Pickhardt PJ, Hassan C, Laghi A, et al. CT colonography to screen for colorectal cancer and aortic aneurysm in the Medicare population: cost-effectiveness analysis. AJR Am J Roentgenol. 2009;192(5):1332-13400.
22. Ramsey SD, Wilschut J, Boer R, et al. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs. Am J Gastroenterol. 2010;105(8):1861-1869.
23. Regge D, Hassan C, Pickhardt PJ, et al. Impact of computer-aided detection on the cost-effectiveness of CT colonography. Radiology. 2009;250(2):488-497.
24. Sharaf RN, Ladabaum U. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Am J Gastroenterol. 2013;108(1):120-132.
25. Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, et al. Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations. Radiology. 2011;261(2):487-498.
26. Vijan S, Hwang I, Inadomi J. The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol. 2007;102(2):380-390.